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Abstract 
X-Ray analysis of the ferritin of Escherichia coli (EC-FTN) and of EC-FTN crystals soaked in (NH,),Fe(SO,), has revealed the presence of three 
iron-binding sites per subunit. Two of these form a di-iron site in the centre of the subunit as has been proposed for the ‘ferroxidase centres’ of human 
ferritin H chains. This di-iron site, lying within the 4-alpha-helix bundle, resemble those of ribonucleotide reductase, methane monoxygenase and 
haemerythrin. The third iron is bound by ligands unique to EC-FTN on the inner surface of the protein shell. It is speculated that this state may 
represent the nucleation centre of a novel type of Fe(III) cluster, recently observed in EC-FTN. 
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1. Introduction 
The mechanism by which the iron-storage protein, fer- 
ritin, stores iron has been the focus of many studies, but 
direct information on the positions of the iron binding 
sites has been lacking until now. Ferritin molecules are 
hollow protein shells, assembled from 24 polypeptide 
chains related by 432 symmetry [l]. The central cavity 
has a capacity for up to 4500 Fe(II1) atoms which are 
stored as a ferric oxyhydroxide-phosphate mineral [I]. 
Depending on the species and on iron loading, the iron- 
cores of natural ferritins vary in composition from phos- 
phate-free ferrihydrite (approximately 5Fe,0,.9H,O) to 
that approaching ferric phosphate [1,2]. In vitro studies 
show that the ferric iron-core is deposited within the 
protein shell, if iron is presented as Fe(I1) [3]. The ability 
of the protein to catalyse Fe(I1) oxidation is well estab- 
lished [4,5], but the catalytic mechanism and the subse- 
quent stages leading to mineralisation are not clearly 
defined. The use of site-directed mutagenesis has impli- 
cated a number of residues in iron-binding [4-71, but one 
of the reasons for the lack of direct information on iron- 
binding positions is that crystallisation of mammalian 
ferritins has always involved metal ions, usually Cd2+ or 
Ca2’ [1,8]. Such metals compete with binding of Fe2’ or 
Fe3’ ions and thus prevent the unequivocal assignment 
of their sites. Although the presence of nucleation sites 
on the cavity surface has also been proposed [3,8-lo], 
their positions are uncertain. This may be due, in part, 
to lack of alignment between the atomic structures of the 
mature mineral crystallites and the protein [l 11. 
Mammalian ferritin shells contain two types of pol- 
ypeptide chain (or subunit) known as H and L. Ferroxi- 
dase activity is associated only with H-type chains. The 
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main function of the non-catalytic L chains is probably 
to promote iron-core nucleation [9,10]. All ferritins of 
invertebrates, plants and bacteria, so far examined, are 
of the H-type, as judged from amino acid sequence align- 
ment and, in some cases, from their Fe(I1) oxidative 
ability [ 121. Two types of ferritin have been isolated from 
Escherichia coli, a haem-containing ‘bacterioferritin’ 
(EC-BFR) [ 131 and a conventional ferritin (EC-FTN) [ 141. 
Both of these resemble mammalian H-chain ferritins [ 121 
and both exhibit ferroxidase activity [14,15]. Although 
EC-BFR contains only five of the seven amino acid resi- 
dues associated with this activity in human H chains, 
EC-FTN contains all seven.[ 121. 
EC-FTN has now been crystallised in the absence of 
metal ions and its three-dimensional structure deter- 
mined at high resolution (Hempstead, Hudson, Yewdall, 
Artymiuk, Andrews, Guest and Harrison, unpublished 
work). Soaking of these crystals with (NH&Fe(S0J2 
solution in air has allowed the identification of three 
iron-binding sites. These sites and other features of the 
three-dimensional structure of EC-FTN are described 
here and discussed in relation to mechanisms of Fe(I1) 
oxidation and mineralisation in ferritin. 
2. Materials and methods 
EC-FTN was isolated from an over-producing strain of E. coli 
JRG2449 as described in [14]. 
Crystals of EC-FTN, 1 .O x 1 .O x 0.8 mm, were grown by micro-dialy- 
sis at 20°C against 20 mM piperazine-HCI buffer, pH 5.2 containing 
0.2 M NaCI. The crystals are in tetragonal space group 14 with dimen- 
sions a = b = 13.0 nm, c = 17.3 nm. Data were collected on an in-house 
SDMW Area Detector, with CuKa radiation. For iron-binding, crys- 
tals were dialysed in air against 20 mM (NH,),Fe(SO,), for 24 h. X-ray 
data were collected at the SERC Daresbury synchrotron source, 0.89 
8, wavelength, using a Mar Research image plate, (Table I). The struc- 
ture of EC-FTN was solved by molecular replacement using six subunits 
of the human H chain ferritin (HuHF) structure [8] as a starting model. 
The orientations of the non-crystallographic fourfold axes in the unit 
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cell were determined by means of a self-rotation function using PO- 
LARRFN 1161. Rigid bodv refinement and simulated annealing were 
then performed u&g XPLOR [17] and conventional refinement was 
carried out using PROLSQ [18]. The metal sites in the iron- loaded 
EC-FTN were located using the program FRODO [19] in a difference 
electron density map (3F,n- 2F,) exp(ia,,,), where PH indicates Ec- 
FTN plus iron and P, native EC-FTN. The structure was refined using 
TNT [20] (details given in Table 1). Refinement of the native EC-FTN 
structure is continuing but iron-binding sites can be unambiguously 
identified in the difference map. The eighteen iron peaks are in the range 
11-7.6 o, the next highest peak, which corresponds to a misplaced 
methionine suplhur atom, is at the 4.7 u level. 
3. Results and discussion 
The three-dimensional structure of EC-FTN closely 
resembles those of other ferritins [1,8]. Its subunit is 
folded as a four-cc-helix bundle with a long loop (external 
to the shell) linking the C-terminus of helix B and the 
N-terminus of helix C at opposite ends of the bundle. 
Like those of mammalian ferritins [1,8], a short fifth 
helix, E, lies roughly along to the radius vector of the 
shell with its C-terminus at the cavity surface. The space- 
group of most previously analysed ferritin crystals is 
F432 with coincidence of molecular 432 and lattice sym- 
metry. The crystallographic subunit contains a single 
chain and thus the 24 subunits are crystallographically 
indistinguishable. In contrast, in the tetragonal unit cell 
of EC-FTN (space-group 14) the asymmetric unit con- 
tains six chains. These subunits, which are related by 
non-crystallographic symmetry, are virtually indistin- 
guishable their a-carbon atoms superimposing to within 
+0.5 A. The chain folds of EC-FTN and HuHF are also 
strikingly similar (cz-carbons superposable to within 
-I 1.1 A), but there are numerous differences in inter- 
subunit interactions, as expected from their low amino 
acid sequence identity (24%). ‘Structural features will be 
described in detail elsewhere and only those regions per- 
taining to metal binding sites will be considered here. 
Three iron-binding sites (presumably Fe3+) are ob- 
served in EC-FTN, lying within about 7 A of each other. 
Electron density for these sites (calculated as the differ- 
ence between iron-containing and iron-free crystals) is 
shown in Fig. 1, together with iron ligands and main 
chain in the immediate neighbourhood of the metal sites. 
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A schematic diagram of the metal sites is shown in 
Fig. 2. 
A striking feature of Fig. 1 is the proximity of the two 
Fe3+ peaks of electron density, A and B, which are 3.8 
A apart (average distance for six subunits). The ligands 
of Fe, are Glu-27, Glu-62 and His-65 and those of Fe, 
are Glu-62 (a bridging ligand), Glu-107 and Glu- 144. 
Gln-141 is not close enough to bind directly to Fe, (or 
to Fe,), but may be linked through water. The corre- 
sponding region of HuHF, which is virtually identical 
except for residue 144, has been shown to bind two Tb3’ 
ions about 3.1 A apart [8]. The estimated occupancy of 
the pair of Fe3’ ions in EC-FTN, Fig. 1, is close to unity, 
indicating that Fe, and Fe, are present in the same sub- 
unit. They may be joined through a p-oxo-bridge (or 
through OH- or H,O), although no electron density sug- 
gesting such a bridge is observed. However, this could be 
due to diffraction effects and the relatively low resolution 
of the analysis. p-oxo-bridged Fe(II1) dimers have been 
observed by Mijssbauer spectroscopy in HuHF [4,5] and 
also recently in EC-FTN [21] as an early product of Fe(I1) 
oxidation. The region of EC-FTN shown in Fig. 2 con- 
tains the seven residues that are highly conserved in fer- 
ritin H chains, namely Glu-27, Tyr-34, Glu-61, Glu-62, 
His-65, Glu-107 and Gln-141. In HuHF this region has 
been identified as the ferroxidase centre with the acid of 
site-directed variants [4-71. Replacements E27A or 
E107A, or E62K plus H65G, lead to marked loss of both 
ferroxidase activity and Fe(II1) dimer production [4-71. 
Substitutions, Y34F and Q141E also lead to lower Fe(I1) 
oxidation rates, but to a less extent than in the above 
[4,7]. An interesting difference between HuHF and Ec- 
FTN is that Glu-144 seems to be able to bind to both Fe, 
and Fe, (see below and Fig. 2). Residue 144 is either 
alanine or serine in the H chains of ferritins from animals 
and plants. 
The studies with HuHF variants outlined above, to- 
gether with computer modelling, led to the proposal that 
the catalytic mechanism of Fe(I1) oxidation involves ox- 
idation of two Fe(I1) atoms with production of hydrogen 
peroxide [6]. It was suggested that oxidation of a close 
pair of Fe(I1) atoms by a single dioxygen molecule, 
bound to one of them, may account for the fast oxidation 
Table 1 




Unique Percentage R merge* R,f** ~bond 
measured reflections completeness (A) 
~a”& 
(“) 
measured of data 
EC-FTN 2.42 240,964 50,555 90.4 0.096 0.25 0.008 1.5 
EC-FTNF+ 2.98 79,474 29,324 99.0 0.090 0.27 0.010 1.9 
Gc-FTNF, crystals soaked in (NH,),Fe(SO,),. 
* &e, = x,, c, 1 I(h), - <I(h)> 1 I & Xj I(hX summed over all measured reflections. 
** Rxr, crystallographic residual, R = C II F, I - I F, 1) I IS I F, 1. 
The mean fractional isomorphous difference was 0.33. ubondr uangle, 
stage of refinement. 
standard deviation of covalent bonds and bond angles, respectively, at current 
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Fig. I. Part of a subunit of EC-FTN showing a difference electron density map between iron-containing and iron-free crystals. Three iron-sites A, 
B and C are shown together with neighbouring side-chains and main chain. The di-iron site, A and B lies in the centre of a subunit and site C lies 
on the inner surface of the protein shell. 
rate. Alternatively oxidation of the two iron atoms may 
occur sequentially [22], but, in EC-BFR, an EPR signal 
has been attributed to an NO-Fe(I1) adduct in which NO 
is bound to a pair of Fe(I1) atoms in [23]. The importance 
of the ‘ferroxidase centre’ region of ferritin H chains in 
Fe(I1) oxidation has been called into question by the 
observation that bullfrog L-chain ferritin fails to catalyse 
oxidation despite the presence of Glu-62 and His-65 [24]. 
However, there are other substitutions (E27K, E107Q, 
Q 14 1 S) in this region of bullfrog ferritin L chains, which 
may prevent any iron-oxidative activity [12]. The results 
of structural analysis given in Figs. 1 and 2 show clearly 
that Fe atoms do bind in this region of EC-FTN. The 
finding of p-oxo-bridged Fe(II1) dimers in EC-FTN [21], 
as well as in HuHF [&7], at very early times after addi- 
tion of Fe(I1) to the apo-proteins, also emphasises the 
importance of an iron-pair in the oxidative mechanism. 
The positions of the two Fe atoms within the 4-helix 
bundle of EC-FTN (Fig. 1) are very similar to the ob- 
served Tb3+ [8] and modelled Fe3’ [6] sites of HuHF. 
Although not shown here, pairs of Tb3+ ions also appear 
in the ferroxidase centre of EC-FTN, when EC-FTN crys- 
tals are soaked with TbCl,, and these Tb3+ ions have the 
same ligands as those of Fe, and Fe, (Banfield, 
Hempstead, Artymiuk and Harrison, unpublished 
work). Hence it may be concluded that the modelled iron 
sites of HuHF are likely to be essentially correct. MSss- 
bauer spectroscopic measurements indicate two slightly 
different modes of binding. Thus both HuHF and Ec- 
FTN give two p-oxo-bridged Fe(II1) dimers distin- 
guished by somewhat different Mossbauer parameters 
[4,5,7,21], due, possibly to variability in the di-iron bridg- 
ing group (e.g. O’- or OH). 
The third iron site, Fee of Figs. 1 and 2 is different 
from any metal site observed in HuHF or in horse spleen 
or rat liver ferritins [ 1,8]. Of its four ligands, Glu-6 1, Glu 
140, Glu 143 and Glu-144 (in its alternative position), 
only Glu-61 is conserved in all known ‘conventional’ 
ferritins (but not in EC-BFR). Glu-140 is also present in 
HuHF and many other ferritins, Glu-144 is unique to the 
two known FTN sequences. Residue 144 is alanine in 
mammalian H and leucine in mammalian L chains [ 121. 
The functional significance, of Fe” at site C is uncertain, 
although it also has a high occupancy. It is possible that 
Fe, is the site of a monomeric Fe(III) species observed 
in Mossbauer spectra of EC-FTN [20]. This species is 
present in a much higher amount in EC-FTN than Fe(II1) 
monomers in HuHF. Moreover, this EC-FTN iron be- 
haves differently from the Fe(II1) monomers in HuHF 
under a variety of conditions [21]. Fe, of Figs. 1 and 2 
Fig. 2. MOLSCRIPT [29] drawing of the iron sites in EC-FTN viewed 
down the axis of the 4-helix bundle. Outside surface of the shell on the 
left, inside on the right. 
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Fig. 3. The di-iron site of EC-FTN compared with those of the ribonu- 
cleotide reductase R2 subunit and haemerythrin. (A) EC-FTN. Gln-141 
cannot bind directly to either FeA or FeB, but may do so through 
water. (B) R2, is based on a drawing in [24]. (C) Hr is from 2hmq 
co-ordinates in the Brookhaven Protein Data Bank. 
is situated on the inner surface and therefore could, in 
principle, represent an iron-core nucleation centre. A 
different nucleation site with ligands not present in Ec- 
FTN, has been postulated for HuHF [8]. The possibility 
of a unique nucleation centre is intriguing and could 
explain another finding of Miissbauer spectral analysis 
[21]. Subspectra ttributed to iron clusters at early stages 
of iron-core formation are more complex than those of 
HuHF or of horse spleen ferritin (HoHF) [25]. Unlike 
HuHF or HoHF in which both magnetic and non-mag- 
netic Fe(II1) clusters resemble the mineral ferrihydrite, 
EC-FTN exhibits two chemically distinct components, 
only one of which is ferrihydrite-like. The other is non- 
magnetic and accounts for about two-thirds of the 
smaller clusters [2 11. 
Other relevant regions of the EC-FTN structure are the 
eight three-fold inter-subunit channels. In crystal struc- 
tures of HuHF and other mammalian ferritins, metal 
ions e.g. Ca*‘, Cd*+, Zn*+ or Tb3+, are found in these 
channels [ 181. Mossbauer spectroscopic investigations 
of site-directed HuHF channel variants have suggested 
that Fe3+ ions can bind in these channels and that they 
are an entry route for Fe2’ [7]. However, the metal li- 
gands Asp- 13 1 and Glu-134 found in the threefold chan- 
nels of HuHF and other ferritins are replaced, in Ec- 
FTN, by asparagine and glutamine respectively. No Fe3’ 
or Tb3+ ions are found in EC-FTN channels, implying 
that such sites are not essential for iron-storage in irre- 
spective of any role they may play in other ferritins. 
The X-ray analysis of the Fe-containing derivative of 
EC-FTN, together with the spectroscopic studies of iron- 
binding to HuHF and EC-FTN described above, estab- 
lish that p-oxo-bridged Fe(II1) dimers form within the 
4-helix bundles of ferritin H chains at the sites depicted 
in Fig. 2. It is interesting to compare these dimers and 
their ligands with those of the ribonucleotide reductase 
R2 component [26] and methane mono-oxygenase 
(MMO) [27] (which closely resemble each other) and of 
haemerythrin (Hr) [28], Fig. 3. Ligands of Fe, are similar 
to those of the corresponding Fe atom of MM0 amd R2. 
They are on the same side of helix B with the bridging 
glutamate (Glu-62) and histidine ligand (His-65) in the 
sequence Glu-X-X-His as found in the other di-iron pro- 
teins [2628]. In Hr the corresponding ligands are spaced 
by three intervening residues and appear in reverse order 
His-X-X-X-Glu. Fe, (Fig. 2) has three amino acid li- 
gands, bridging ligand Glu-62, Glu-107 and Glu-144 (ab- 
sent from other species), with no histidines, unlike the 
corresponding Fe atom of MM0 (and R2) where the 
sequence Glu-X-X-His again relates two of its ligands. 
Fe, has four amino acid ligands (including the glutamate 
bridge) in MM0 and R2, and five in Hr (glutamate and 
aspartate bridges and three histidines). It is possible that 
in EC-FTN Glu-61 could swing into an alternative posi- 
tion to become a third ligand of Fe,, as found for Tb, 
in HuHF [8]. However, there is no indication in the 
EC-FTN electron density map for such alternative con- 
formations. The unique design of the di-iron site in H 
chain ferritins, with its relative ligand paucity, may re- 
flect the fact that Fe is the substrate, not part of the 
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binding site of another substrate, and that it must be able 
to leave the catalytic site after oxidation [4,8]. It is con- 
ceivable that only one Fe atom is released from the 
ferroxidase site to move into the cavity for iron-core 
formation and that the other Fe atom remains. Such a 
possibility has been envisaged for EC-BFR [15]. 
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